These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16466998)

  • 21. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
    Chu E; Allegra CJ
    Adv Exp Med Biol; 1993; 339():143-51; discussion 165-7. PubMed ID: 8178713
    [No Abstract]   [Full Text] [Related]  

  • 22. [Do advances in molecular biology change indications for adjuvant chemotherapy in colorectal cancer?].
    Roque I; Michel P
    Gastroenterol Clin Biol; 2001; 25(8-9):837-8. PubMed ID: 11697319
    [No Abstract]   [Full Text] [Related]  

  • 23. Oncologists' current opinion on the treatment of colon carcinoma.
    Majer M; Akerley W; Kuwada SK
    Anticancer Agents Med Chem; 2007 Sep; 7(5):492-503. PubMed ID: 17896910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer.
    Yip D
    Med J Aust; 1999 Mar; 170(6):283; author reply 284. PubMed ID: 10212654
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 26. Metastatic colon cancer to the ovaries in a Krukenberg-like pattern.
    Traina TA; Leonard GD; Tang L; Paty PB; Maki RG
    J Clin Oncol; 2005 Aug; 23(22):5255-6. PubMed ID: 16051968
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 28. New cancer drugs might help treat HIV--but research not done.
    James JS
    AIDS Treat News; 2002 Apr; (379):5-6. PubMed ID: 12030223
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.
    Alberts SR
    IDrugs; 2007 Oct; 10(10):693-5. PubMed ID: 17899484
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete remission of metastatic colorectal cancer: a pitfall in a multidrug resistance reversal trial.
    Linn SC; Giaccone G; Pinedo HM
    Lancet; 1994 Jun; 343(8913):1648-9. PubMed ID: 7911960
    [No Abstract]   [Full Text] [Related]  

  • 31. Quest for new and better colon cancer treatments picks up steam.
    Nelson NJ
    J Natl Cancer Inst; 1998 Dec; 90(24):1858-9. PubMed ID: 9862617
    [No Abstract]   [Full Text] [Related]  

  • 32. Figuring out what works in education.
    Fink A
    Science; 2004 Sep; 305(5691):1715. PubMed ID: 15375248
    [No Abstract]   [Full Text] [Related]  

  • 33. Figuring out how I belong.
    Nording ML
    Science; 2018 Mar; 359(6383):1558. PubMed ID: 29599248
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy.
    Yang C; Merlin D
    Nanomaterials (Basel); 2020 Jul; 10(7):. PubMed ID: 32708193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies on the management of clinical situations with low therapeutic effectiveness in oncology.
    Expósito J; Bretón JJ; Domínguez C; Pons J
    Clin Transl Oncol; 2010 Jul; 12(7):493-8. PubMed ID: 20615826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
    Dewald GW; Smyrk TC; Thorland EC; McWilliams RR; Van Dyke DL; Keefe JG; Belongie KJ; Smoley SA; Knutson DL; Fink SR; Wiktor AE; Petersen GM
    Mayo Clin Proc; 2009 Sep; 84(9):801-10. PubMed ID: 19720778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target practice: figuring out which, when, and why to use systemic therapies for metastatic colon cancer.
    Holen KD
    Cancer Invest; 2006 Feb; 24(1):98-105. PubMed ID: 16466998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
    Engstrom PF;
    Pharmacotherapy; 2008 Nov; 28(11 Pt 2):18S-22S. PubMed ID: 18980548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.